Arjuna Natural Ltd. has been granted a new patent in Europe for its applied technology of improving the bioavailability of curcumin in its BCM-95® (Curcugreen®) formulation—a product in its portfolio of natural ingredients.
April 11, 2019
The new patent enables Arjuna to further expand its hold in 20 additional countries across Western and Eastern Europe, and is already protected by 49 patents for composition and manufacturing processes of curcumin extract. The patented formulation provides biologically active curcumin with essential oil of turmeric. The 100% natural formulation is backed by over 55 published studies worldwide and several ongoing studies for its therapeutic activity on multiple health indications.
“The composition of BCM-95® (Curcugreen®) contains only turmeric-based components and no synthetic or non-turmeric ingredients,” says Benny Antony, PhD, Joint Managing Director for Arjuna. “This composition of turmeric delivers free curcumin into blood and is retained in the body for longer duration,” notes Antony.
This patent in effect helps to address much confusion in the market regarding curcumin absorption and oral bioavailability. The concern for curcumin is that it is not absorbed nor retained well in the blood stream. The market has subsequently been flooded with curcumin products laden with synthetic additives in attempts to overcome the issue of bioavailability. Also it is observed that many brands are toll manufactured at production centers not complying to cGMP standards.
“Any supplement you put into your body should be both safe and effective,” insists Antony. “Arjuna’s BCM-95® (Curcugreen®) is wholly manufactured in its own facility under a fully automated cGMP complied continuous extraction plant—using only solar power. This has enabled Arjuna to triple its manufacturing capacity in Coimbatore, India to meet the growing demand for their brand of curcumin in coming years."
